Solvay Ventures was among the participants in a series A round for 3D-printed medical technology developer PrinterPrezz.

The digital medicine provider has closed a round led by SoftBank Vision Fund 2 that also featured Novartis, taking its total funding to at least $214m.

Heidelberg and Inserm have scored exits after an acquisition that followed MYR's chronic hepatitis delta virus treatment receiving European regulatory approval.

Alexandria Venture Investments has helped RNA drug developer Remix Therapeutics launch with seed and series A funding.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The underwriters have taken up the over-allotment option in BMS and Celgene-backed oncology drug developer Silverback's initial public offering.

Alexandria Venture Investments was among the participants in the cancer radiotherapy startup's second round in under two months.

Lilly Asia Ventures co-led the first round for the CNS disease drug developer, which is headed by one of its former venture partners.

Stanford University supplied capital to help its AI cell analysis spinout Deepcell close its second funding round.

Science Creates will combine a $20m fund with wet-lab incubation to foster the west of England deep tech ecosystem in partnership with University of Bristol.